Aquaretic

An aquaretic is a novel class of drug that is used to promote aquaresis, the excretion of water without electrolyte loss.[1] Strictly speaking, aquaretics are not diuretics, but are sometimes classified as such.

Aquaresis is preferable to diuresis in the treatment of hyponatremia.

Pharmacokinetics

Aquaretics increase urine output without increasing sodium and chloride excretion, thus causing an increase in urine whilst retaining electrolytes.[2]

Examples

A number of herbal medicines are classified as aquaretics, for example common horsetail or common nettle leaves.[3]

Synthetic aquaretics are vasopressin receptor antagonists, such conivaptan, tolvaptan, demeclocycline and mozavaptan (OPC-31260), as well as lithium. Conivaptan hydrochloride and tolvaptan have been approved by the FDA for treating syndrome of inappropriate antidiuretic hormone (SIADH). [4][5] Mozavaptan is approved in Japan.

References
  1. Nicholas H. Fiebach; Lee Randol Barker (2007). Principles of Ambulatory Medicine. Lippincott Williams & Wilkins. p. 1390. ISBN 0-7817-6227-8.
  2. George M. Brenner; Craig W. Stevens (2013). Phamacology. Elsevier Inc. pp. 120–129. ISBN 978-1455702824.
  3. Lucinda G. Miller; Wallace J. Murray (1998). Herbal Medicinals: A Clinician's Guide. Haworth Press. pp. 147. ISBN 0-7890-0466-6.
  4. "Vaprisol" (PDF). fda.gov. 31 December 2005. Retrieved 6 January 2019.
  5. "Samsca" (PDF). fda.gov. 31 May 2009. Retrieved 6 January 2019.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.